Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-26

Clinical Trial Update: Efficacy of Seluang Fish Oil (Rasbora Argyrotaenia) and Synbiotics Supplementation on CD4+CD25+ Foxp3+ T-regulator Cells, IL17/IL-10 Ratio, and Disease Activity in Systemic Lupus Erythematosus Patients [NA]

View source ↗

Summary

A clinical trial is evaluating whether Seluang fish oil and synbiotic supplementation affect immune markers and disease activity in systemic lupus erythematosus…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Seluang fish oil (Rasbora argyrotaenia) (Seluang fish oil)
  • Synbiotics supplement (Synbiotics)

Snippet

Sponsor: Universitas Sriwijaya | Conditions: Systemic Lupus Erythematosus (SLE) | NA | Status: ACTIVE_NOT_RECRUITING